Skip to main content
. 2015 Feb 12;6(22):19328–19335. doi: 10.18632/oncotarget.2896

Table 2. Plasma samples from patients with epithelial ovarian cancer and healthy donors analyzed by RT-PCR.

Plasma Sample Number HMGA2 HMGA2 +
Ovarian Cancers (n. 47) 7 (14.9%) 40 (85.1%)
Healthy donors (n. 23) 23 (100%) 0